[“HELICARB”-俄罗斯首款含99% c -尿素的幽门螺杆菌呼吸测试试剂盒:从想法到注册]。

R. Plavnik, S. Rapoport, K. Plavnik, A. R. Elman, V. I. Nevmerzhickij
{"title":"[“HELICARB”-俄罗斯首款含99% c -尿素的幽门螺杆菌呼吸测试试剂盒:从想法到注册]。","authors":"R. Plavnik, S. Rapoport, K. Plavnik, A. R. Elman, V. I. Nevmerzhickij","doi":"10.18821/0023-2149-2017-95-1-78-84","DOIUrl":null,"url":null,"abstract":"The present study was aimed to develop and introduce in medical practice the first Russian kit for the C-urea breath test of Helicobacter pylori. The newly created kit was given the commercial name «HELICARB» and successfully passed technical, toxicological, clinical, and laboratory testing. The optimal dose of 13C-urea was determined and various devices needed to perform the test were compared. The results were approved by the Federal Service for Supervision in the health sector Roszdravnadzor) that issued the Registration certificate № RZN 2016/3773 (order № 1641 of 02.29.2016), which gives the right to manufacture and use the «HELICARB» test kit at the territory of the Russian Federation.","PeriodicalId":17856,"journal":{"name":"Klinicheskaia meditsina","volume":"152 1","pages":"78-84"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"[\\\"HELICARB\\\" - the first Russian breath test kit with 99 % C-urea for Helicobacter pylori: from idea to registration].\",\"authors\":\"R. Plavnik, S. Rapoport, K. Plavnik, A. R. Elman, V. I. Nevmerzhickij\",\"doi\":\"10.18821/0023-2149-2017-95-1-78-84\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The present study was aimed to develop and introduce in medical practice the first Russian kit for the C-urea breath test of Helicobacter pylori. The newly created kit was given the commercial name «HELICARB» and successfully passed technical, toxicological, clinical, and laboratory testing. The optimal dose of 13C-urea was determined and various devices needed to perform the test were compared. The results were approved by the Federal Service for Supervision in the health sector Roszdravnadzor) that issued the Registration certificate № RZN 2016/3773 (order № 1641 of 02.29.2016), which gives the right to manufacture and use the «HELICARB» test kit at the territory of the Russian Federation.\",\"PeriodicalId\":17856,\"journal\":{\"name\":\"Klinicheskaia meditsina\",\"volume\":\"152 1\",\"pages\":\"78-84\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Klinicheskaia meditsina\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18821/0023-2149-2017-95-1-78-84\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klinicheskaia meditsina","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18821/0023-2149-2017-95-1-78-84","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

摘要

本研究旨在开发并在医疗实践中引入第一个俄罗斯试剂盒用于幽门螺杆菌c -尿素呼气试验。新创建的试剂盒被赋予商业名称«HELICARB»,并成功地通过了技术、毒理学、临床和实验室测试。确定了13c -尿素的最佳剂量,并比较了进行试验所需的各种装置。结果得到了联邦卫生部门监督局(Roszdravnadzor)的批准,并颁发了№RZN 2016/3773注册证书(2016年2月29日第1641号命令),该证书授予了在俄罗斯联邦境内生产和使用“HELICARB”检测试剂盒的权利。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
["HELICARB" - the first Russian breath test kit with 99 % C-urea for Helicobacter pylori: from idea to registration].
The present study was aimed to develop and introduce in medical practice the first Russian kit for the C-urea breath test of Helicobacter pylori. The newly created kit was given the commercial name «HELICARB» and successfully passed technical, toxicological, clinical, and laboratory testing. The optimal dose of 13C-urea was determined and various devices needed to perform the test were compared. The results were approved by the Federal Service for Supervision in the health sector Roszdravnadzor) that issued the Registration certificate № RZN 2016/3773 (order № 1641 of 02.29.2016), which gives the right to manufacture and use the «HELICARB» test kit at the territory of the Russian Federation.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信